BioSpace News Archive

Deals

Sensient Declares Dividend - April 25, 2019

The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.36 per share.

April 25, 2019
·
1 min read
Deals

Green Growth Brands Offer for Aphria Inc. Expires

Green Growth Brands Inc. announces that its formal offer (the “Offer”) to acquire all of the issued and outstanding common shares of Aphria Inc.

April 25, 2019
·
2 min read
Deals

Aphria Announces Expiry and Termination of Green Growth Brands Take-Over Bid

Aphria Inc. announced that the previously announced take-over bid by Green Growth Brands Inc. has failed to meet the statutory minimum tender condition and has now expired and is terminated.

April 25, 2019
·
4 min read
Business

Docutrax Selected to Oversee New Subcontractor Compliance Program of ProSight Specialty Insurance

A custom risk control solution to monitor insurance coverage of General Contractor subs

April 25, 2019
·
1 min read
Drug Development

Gencove announces Phase I SBIR grant to validate polygenic risk score estimation from low-pass sequencing

Gencove, the leading low-pass sequencing platform announced the receipt of a Phase I grant from the National Cancer Institute under the auspices of the Small Business Innovation Research program of the National Institutes of Health.

April 25, 2019
·
2 min read
Biotech Bay

Robotic Germ Zapper Helps Bring Down Infectious Disease

A germ-zapping robot called LightStrike from Xenex is used at California Pacific Medical Center hospitals to help curb the spread of infectious diseases.

April 25, 2019
·
3 min read
Genetown

MilliporeSigma Introduces New Greener Solvent, Cyrene™

New bio-derived product is a safer, more sustainable alternative for Dimethylformamide and N-Methyl-2-pyrrolidone solvents

April 25, 2019
·
5 min read
BioMidwest

Pharmacy Inventory Management Using a Temperature Monitoring System

Grant Data Logger Helps Pharmacy Maintain Quality Control

April 25, 2019
·
3 min read
Business

Expesicor and Novoron Bioscience Sign Collaboration Agreement to Develop Neuro-regenerative Compounds for Epilepsy, Alzheimer’s Disease, and ALS

Expesicor announced an official collaboration agreement with Novoron Bioscience, a private, San Diego-based biotechnology company developing novel therapeutic approaches to address disorders of the central nervous system.

April 25, 2019
·
3 min read
Deals

Assertio therapeutics to report first quarter 2019 financial results after the close of markets on wednesday, may 8, 2019

Assertio Therapeutics, Inc. announced that it will release first quarter 2019 financial results on Wednesday, May 8, 2019, after the close of markets.

April 25, 2019
·
1 min read